AMP-activated protein kinase (AMPK) is becoming recognized as a critical regulator of energy metabolism in cells. Using a mouse model in which we specifically blocked AMPK activity in muscles, we have demonstrated that activation of AMPK is necessary for the effects of 5-aminoimidazole-4-carboxamide riboside ('AICAR') and hypoxia, and is possibly required for a portion of exercise-induced glucose uptake. These same mice could not maintain sufficient glycogen in their skeletal muscle and it was rapidly depleted when the animals were subjected to mild exercise. Using isolated strips, we observed muscle hypertrophy and increased tiredness in the AMPK-deficient muscle. We also performed microarray analysis and showed dramatic changes of transcription profile in muscles of the lazy mice. These could have a significant impact on muscle function and may contribute to the observed phenotype.
Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'
Unfortunately, AICAR is likely to mimic many of the physiological effects of AMP, and thus its action is not limited to modulation of AMPK [7] . Nonetheless, with recent interest in the idea that AMPK might mediate the ability of contraction to stimulate glucose uptake and fatty acid oxidation, AICAR treatment was shown to promote the metabolic responses. A correlation between AICAR-stimulated AMPK activation and glucose uptake was shown by muscle perfusion and in experiments ex vivo [6, 8] . Interestingly, the AICAR-induced glucose uptake in skeletal muscle was insulin-independent, but not additive to contraction-stimulated glucose transport [8] . These observations supported the idea that AMPK might be the kinase mediating muscle contraction-or exerciseinduced glucose uptake. Because a specific inhibitor of AMPK has not been available, in order to prove that the AICARmediated effect on glucose transport is indeed dependent on AMPK, we decided to generate mice deficient in AMPK activity in muscle [9] .
To accomplish this, we introduced a mutation in the AMPK α2 catalytic subunit, Lys 45 →Arg (K45R), which renders the enzyme deficient in activity, as confirmed by transient expression studies; we term this the kinase-dead, or KD, mutation. Mice expressing wild-type and K45R-mutated AMPK α2 subunits were generated under the control of the muscle creatine kinase ('MCK') promoter, which drives transgene expression in skeletal and, to a lesser extent, cardiac muscle [9] . Chronic expression of the inactive form of AMPKα, such as the K45R mutant, under a strong promoter resulted in a replacement of endogenous wildtype α subunit by the transgene product [9] . This occurs because the total level of AMPKα (α1 and α2) is highly regulated in cells, in essence limited by the available AMPK β and γ subunits. Under normal conditions, these are kept constant, so that α subunit is synthesized in excess and is therefore free to be rapidly degraded [10, 11] . In mouse lines expressing high levels of KD α, the transgene product displaces wild-type catalytic subunit from the heterotrimeric complex, and endogenous α is degraded. For this reason, we could detect only transgene product, and not endogenous AMPKα subunits [9] . One would expect AMPK to be inactivated in KD-expressing tissues so that the latter serves as a dominant negative (DN). The prediction was confirmed as we showed by immune complex kinase assay a reduction in AMPK activity in KD-expressing muscle, both in the basal state and following muscle contraction [9] . As a control, we showed that transgenic mice carrying wild-type AMPKα2 subunit displayed AMPK activity comparable with that in non-transgenic (NTG) mice. Phosphorylation of AMPKα was intact in muscles of DN AMPK mice, as demonstrated by increased reactivity with an antibody specific for AMPKα phosphorylated at Thr 172 after contraction [9] . Interestingly, basal phosphorylation of Thr 172 was higher in DN AMPK mice compared with that in NTG mice or mice expressing wild-type AMPKα, suggesting that a negative feedback signal tries to overcome or compensate for the inhibited AMPK activity. The DN strategy to block AMPK activity appears to be specific; in particular, the insulin-signalling pathway was not affected in DN AMPK mice [9] .
Using these DN AMPK transgenic mice as a tool, we showed that AICAR-induced glucose uptake was blocked by AMPK inactivation, formally demonstrating that AMPK is the effector of AICAR-dependent glucose uptake in skeletal muscle [9] . Injection of AICAR into NTG mice resulted in an insulinomimetic-hypoglycaemic effect. However, this was partially blocked in DN AMPK mice, suggesting that AMPKdependent glucose transport contributes significantly to the blood-glucose-lowering effect of AICAR, in contrast with previous studies suggesting that inhibition of hepatic gluconeogenesis and glycogenolysis is the predominant site of AICAR action [9] . Our results also showed that AMPK
Figure 1 Glycogen levels in gastrocnemius muscles of sedentary and treadmill-run NTG and DN (KD) AMPK mice
Mice were subjected to treadmill running for 30 min and allowed to recover for the indicated period of time before their muscles were dissected and glycogen concentration was analysed. Values are means ± S.E.M. for n = 6 or 7 in each group.
is necessary for hypoxia-induced hexose transport and Glut4 translocation in isolated skeletal muscle. It has been recognized for some time that contraction and hypoxia, and more recently AICAR, stimulates hexose transport by effecting the translocation of a specialized type of glucose carrier, Glut4, from an intracellular compartment to the sarcolemma and T-tubules [12] . However, we were surprised to find that suppression of AMPK only partially inhibited contraction-induced hexose transport in skeletal muscle. Putting these data together, our findings suggest that AMPK is an important mediator of muscle contraction-and exerciseinduced glucose transport, but indicate that other unidentified factor(s) are also involved in this process [9] . However, other alternative interpretations are compatible with these data. For example, it is possible that distinct signalling pathways convey the signal from different levels of exercise or work. Perhaps, AMPK-independent pathways signal low levels of work, and AMPK comes into play only after severe exertion. Lastly, it still remains possible that contractioninduced glucose uptake is completely independent of AMPK, but under the experimental conditions we employed for electrically induced muscle contraction, we have induced regions of hypoxia within the muscle. Inactivation of AMPK in muscles also resulted in an obvious but rather unexpected change in the behaviour of these mice. In a spontaneous running test in which mice were individually caged and allowed free access to exercise wheels, DN AMPK mice showed a 20-30% reduction in activity during the active (dark) cycle [9] . Similarly, using detection of beam breaking as a measurement of activity, we could also detect significant less spontaneous activity in DN AMPK mice (results not shown). When mice were forced to run on treadmills under varying conditions, DN AMPK mice became tired significantly faster than NTG animals, frequently falling off the track. The reason for reduced spontaneous activity and exercise intolerance in DN AMPK mice is not fully clear to us at present, but, since the transgene is also expressed in heart, impaired cardiac function could play a role.
One of the possible reasons for reduced exercise capacity in DN AMPK mice might be the reduced muscle glycogen content. Previously, we reported that glycogen concentration in sedentary DN AMPK mice was about half of that of NTG mice [9] . Our recent experiments showed that when mice were subjected to mild treadmill running, the glycogen level in gastrocnemius muscle of DN AMPK mice was depleted quickly and its resynthesis after termination of exercise was slow compared with that of NTG littermates (Figure 1) . Under basal conditions, glycogen synthase activity tended to be higher and glycogen phosphorylase activity lower in DN AMPK muscles. However, we could not detect a significant difference in glycogen synthase or glycogen phosphorylase activities in muscles of DN AMPK mice and those of their wild-type littermates after contraction (Figure 2) . Body composition analysis revealed that the percentage of water in DN mice was lower than that in NTG mice (46% and 55% in DN and NTG mice respectively; P = 0.014, n = 6) Table 2 Summary of transcription profile changes in DN AMPK mice
Genes up-or down-regulated 2-fold or more in DN AMPK mice are divided into categories based on their known functions.
Increased in Decreased in

DN AMPK DN AMPK
Energy metabolism 27 9
Cell signalling 64 26
Growth and proliferation 2 6
Secretory and trafficking 6 10 Transcription and translation 40 9
Cytoskeletal proteins 3 8
Immune response 9 3
Cell surface and matrix 11 5 Others 72 54
while the fat and protein levels are comparable in these mice. Reduced water content is probably related to lower glycogen concentration in DN AMPK mice. Because of the reduced exercise tolerance, we studied more directly the contractile properties of skeletal muscle excised from the DN AMPK mice in order to test whether the impaired exercise tolerance was due to problems inherent to skeletal muscle. These muscles tended to be larger, though the hypertrophy did not result in greater forces. In fact, specific force (force/cross-sectional area) was significantly lower in DN transgenic mice [extensor digitorum longus (EDL):NTG is 20.8 ± 0.4 N/cm 2 , compared with 18.4 ± 1.0 N/cm 2 for DN AMPK mice] (Table 1 ). There were no readily detectable differences in the histology of the muscle to explain the hypertrophy or the muscle weakness. Fatigue was examined by examining the force generation in isolated muscle strips, and again showed that EDL muscles from DN AMPK mice generated significantly less force than those from their NTG littermates, after 1 min of tetanic contractions. Recovery from fatigue was also impaired, particularly at later time points (Figure 3 ). This could have been caused by a problem in utilizing fuels efficiently, or by a defect intrinsic to the contractile apparatus. AMPK has been shown to play an important role in gene transcription in several systems, including yeast, liver cells and muscle. For example, Glut4, hexokinase and several mitochondrial enzymes have been implicated as being regulated by AMPK, based upon AICAR-induced expression in skeletal muscle [13] [14] [15] . We wondered whether changes of gene expression contribute to the phenotypic changes in DN AMPK mice. To study AMPK-regulated gene transcription with a systematic approach, we decided to use DNA microarrays. RNA extracted from EDL muscles from NTG and DN AMPK mice was used to generate labelled cRNA, which was hybridized to the Affymetrix U74 probe sets. Two independent experiments were performed and the results were analysed as replicates. Genes judged as being 
